Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 14;26(38):5797-5811.
doi: 10.3748/wjg.v26.i38.5797.

Gastrointestinal complications after kidney transplantation

Affiliations
Review

Gastrointestinal complications after kidney transplantation

Rossella Gioco et al. World J Gastroenterol. .

Abstract

Gastrointestinal complications are common after renal transplantation, and they have a wide clinical spectrum, varying from diarrhoea to post-transplant inflammatory bowel disease (IBD). Chronic immunosuppression may increase the risk of post-transplant infection and medication-related injury and may also be responsible for IBD in kidney transplant re-cipients despite immunosuppression. Differentiating the various forms of post-transplant colitis is challenging, since most have similar clinical and histological features. Drug-related colitis are the most frequently encountered colitis after kidney transplantation, particularly those related to the chronic use of mycophenolate mofetil, while de novo IBDs are quite rare. This review will explore colitis after kidney transplantation, with a particular focus on different clinical and histological features, attempting to clearly identify the right treatment, thereby improving the final outcome of patients.

Keywords: Colitis; Crohn disease; Cytomegalovirus; Inflammatory bowel disease; Kidney transplantation; Mycophenolate mofetil; Mycophenolate mofetil colitis; Solid organ transplantation; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare no conflicts of interest for this article.

Figures

Figure 1
Figure 1
Cytomegalovirus colitis. A: Positivity for early cytomegalovirus antigen on immunochemistry; and B: Positivity for Ki-67 antigen on immunochemistry.

Similar articles

Cited by

References

    1. Veroux M, Corona D, Veroux P. Kidney transplantation: future challenges. Minerva Chir. 2009;64:75–100. - PubMed
    1. Heemann U, Abramowicz D, Spasovski G, Vanholder R European Renal Best Practice Work Group on Kidney Transplantation. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant. 2011;26:2099–2106. - PubMed
    1. Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D, Tallarita T, Zerbo D, Virgilio C, Sciacca A, Cappello D, Stefani S, Veroux P. Infective complications in renal allograft recipients: epidemiology and outcome. Transplant Proc. 2008;40:1873–1876. - PubMed
    1. Gioco R, Corona D, Agodi A, Privitera F, Barchitta M, Giaquinta A, Alba I, D'Errico S, Pinto F, De Pasquale C, Pistorio ML, Veroux P, Veroux M. De Novo Cancer Incidence and Prognosis After Kidney Transplantation: A Single Center Analysis. Transplant Proc. 2019;51:2927–2930. - PubMed
    1. Pittman ME, Jessurun J, Yantiss RK. Differentiating Posttransplant Inflammatory Bowel Disease and Other Colitides in Renal Transplant Patients. Am J Surg Pathol. 2017;41:1666–1674. - PubMed